Small Bowel Disease Clinical Trial
— TMSETOfficial title:
Total Motorized Spiral Enteroscopy Trial
Study design Prospective bicentric non-controlled clinical trial
Study purpose
- to evaluate the efficacy and safety of Novel Motorized Spiral Enteroscopy (NMSE) for total
enteroscopy in patients with suspected small bowel diseases with an indication for direct
visualization of the entire small bowel
Primary objective
Rate of total enteroscopy by means of NMSE with:
1. a complete anterograde approach
2. or a combined anterograde and retrograde approach
Secondary objectives
- Procedural success of anterograde and retrograde approach
- Procedural time (minutes)
- Depth of maximum insertion (cm)
- Diagnostic yield
- Therapeutic yield
- Adverse events
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | February 28, 2019 |
Est. primary completion date | February 21, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients with small bowel disease with an indication for a total enteroscopy, e.g.: - Overt obscure gastrointestinal bleeding or obscure gastrointestinal bleeding or indeterminate iron-deficiency anaemia and positive Video capsule endoscopy (VCE) or negative VCE in patients who have ongoing bleeding shown by overt bleeding or continued need for blood transfusions - Abdominal pain or chronic diarrhoea with positive findings of small bowel imaging examinations - Noncontributory ileocolonoscopy and suspicion of Crohn's disease on small-bowel cross-sectional imaging modalities or small-bowel capsule endoscopy - Further evaluation of known Crohn`s disease or therapeutic indications in Crohn`s disease - Large polyps (>10-15mm) in the jejunum and ileum discovered by radiological examination or small-bowel capsule endoscopy in patients with Peutz-Jeghers syndrome - Nonresponsive or refractory coeliac disease Exclusion Criteria: - - Age under 18 years - Health status American Society of Anesthesists Classification (ASA) 4 - Pregnancy - Coagulopathy (INR=2.0, Platelets < 70/nl) - Taking anti-platelet agents or anticoagulants (other than aspirin) within last 7 days - Any medical contraindication to standard enteroscopy - Presence of any intraluminal or extraluminal foreign body in the abdominal cavity - Any prior gastric, small bowel or colonic surgery, or implantable devices in these locations (cardiac pacemakers and non-abdominal implants are acceptable) - Known or suspected bowel obstruction or stenosis or history of bowel obstruction - Known coagulation disorder - Known or suspected esophageal stricture or Schatzki ring - Known gastric or esophageal varices - Suspected perforation of the GI tract - Known or suspected colonic or ileocecal valve (ICV) stricture - Inability to tolerate sedation or general anesthesia for any reason - Inability to tolerate endotracheal intubation - Absence of a signed informed consent |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Evangelisches Krankenhaus Düsseldorf | Université Libre de Bruxelles |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of total enteroscopy by Motorized Spiral Enteroscopy | Total enteroscopy by: a complete anterograde approach or a combined anterograde and retrograde approach |
2 days | |
Secondary | Procedural Success Rate | of anterograde and retrograde approach | 2 days | |
Secondary | Procedural time | of anterograde and retrograde approach | 2 days | |
Secondary | Depth of maximum insertion to the small bowel | anterograde and retrograde | 2 days | |
Secondary | Diagnostic yield | anterograde and retrograde | 2 days | |
Secondary | Therapeutic yield | anterograde and retrograde | 2 days | |
Secondary | Adverse events | anterograde and retrograde, serious adverse events | 3 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05086471 -
Performance Evaluation of the NaviCam SB Capsule Endoscope System for the Diagnosis of Small Bowel Diseases
|
N/A | |
Completed |
NCT05548140 -
Novel Motorized Spiral Enteroscopy Vs Single Balloon Enteroscopy In Patients With Small Bowel Disorders- A RCT
|
N/A | |
Completed |
NCT03955081 -
A Clinical Study With the Medical Device PowerSpiral for Deep Enteroscopy
|
||
Recruiting |
NCT03321669 -
Impact of Diet on Capsule Endoscopy
|
N/A | |
Completed |
NCT04186390 -
Learning Small Bowel Capsule Endoscopy
|
||
Recruiting |
NCT04152239 -
Utility of Motorized Spiral Enteroscopy for Suspected Small Bowel Pathology
|
||
Completed |
NCT01088646 -
Evaluation of PillCam® Express Capsule Endoscopy Delivery System
|
N/A | |
Not yet recruiting |
NCT05522101 -
Mini-sized MCE for Detection of Small Bowel in Children Under the Age of 10 Years
|
N/A | |
Completed |
NCT05182983 -
Tongue Image Database and Diagnostic Model for Digestive Tract Disease Diagnosis
|
||
Completed |
NCT04884113 -
PowerSpiral Enteroscopy Performance and Safety
|
||
Recruiting |
NCT04959994 -
Small Bowel Evaluation Using Novel Motorized Spiral Enteroscopy
|
||
Completed |
NCT03482661 -
Magnetic Steering Improves Small Bowel Capsule Endoscopy Completion Rate
|
N/A | |
Not yet recruiting |
NCT05408910 -
Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis
|
Phase 2/Phase 3 | |
Completed |
NCT02486536 -
The Best Dosage and Timing of Polyethylene Glycol for Bowel Preparation Before Capsule Endoscopy
|
Phase 4 | |
Recruiting |
NCT05004207 -
Study of Oro-cecal Transit Time in Healthy Subjects Using Scintigraphy and Lactulose Hydrogen Breath Test.
|
||
Recruiting |
NCT00275184 -
Bowel Preparation and Prokinetics in Capsule Endoscopy
|
Phase 3 | |
Recruiting |
NCT06111131 -
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
|
N/A | |
Completed |
NCT05228379 -
Small Bowel Capsule Endoscopy: Experience From a Single Large Tertiary Care Centre
|
||
Suspended |
NCT03990207 -
The PowerSpiral Antegrade Investigational Device Exemption (IDE) Study
|
N/A | |
Recruiting |
NCT03962283 -
Rifaximin and Misoprostol Combination Therapy for Healing of Small Bowel Ulcers in Aspirin Users
|
Phase 2/Phase 3 |